Related Experiment Video

Updated: Sep 28, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.1K

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration

Wan He1, Gengpeng Lin2, Chaohu Pan3,4,5

  • 1Department of Oncology, Shenzhen People's Hospital, Shenzhen, China.

Frontiers in Genetics
|April 1, 2022
PubMed

Abstract:

[This corrects the article DOI: 10.3389/fgene.2022.761681.].

Keywords:
RNA modification “writers”WM scoreimmunotherapylung adenocarcinomatumor microenvironment

More Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.2K

Related Experiment Videos

Last Updated: Sep 28, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.1K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
10:33

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts

Published on: April 29, 2014

11.2K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K

Articles linked to this work by shared authors, journal, and citation graph.

Visible-light-enabled multicomponent synthesis of selenotetrazoles and selenocarbamates.

Chemical communications (Cambridge, England)·2026

Using machine learning to predict student mathematics performance in six East Asian countries: evidence from PISA 2022.

Frontiers in psychology·2026

Crizotinib or vebreltinib response and resistance in advanced non-small cell lung cancer with MET exon 14 skipping.

Discover oncology·2026

Single-cell spatial transcriptomics reveals tumor microenvironment heterogeneity in primary and lymph node-metastatic small cell lung cancer.

Cell reports. Medicine·2026

Novel NOTCH2-NTRK1 fusion confers osimertinib resistance in EGFR-mutant non-small cell lung cancer by interacting with EGFR.

Translational oncology·2025

Light-adaptive interfacial solar steam evaporation enhanced by dynamic water gating.

Nature communications·2025

Integrated proteomic and metabolomic analyses define the molecular architecture of acute mountain sickness.

Frontiers in genetics·2026

Preclinical evaluation of AL-001, a gene therapy for wet age-related macular degeneration.

Frontiers in genetics·2026

Glycogen storage disease type VII (Tarui disease): a case report presenting a PFKM variant previously described only in canine models.

Frontiers in genetics·2026

Clinical implementation of next-generation sequencing in tertiary health system: the Rijeka retrospective study.

Frontiers in genetics·2026

DNA damage repair gene defects combined predict the efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: a retrospective cohort study.

Frontiers in genetics·2026

Correction: Editorial: Hepatocellular carcinoma: from bench to bedside.

Frontiers in genetics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us